首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
EFFECT OF NIFEDIPINE ON ANTIPYRINE AND THEOPHYLLINE DISPOSITION
被引:8
作者
:
ADEBAYO, GI
论文数:
0
引用数:
0
h-index:
0
机构:
COLL MED LAGOS,DEPT PHARMACOL,LAGOS,NIGERIA
COLL MED LAGOS,DEPT PHARMACOL,LAGOS,NIGERIA
ADEBAYO, GI
[
1
]
MABADEJE, AFB
论文数:
0
引用数:
0
h-index:
0
机构:
COLL MED LAGOS,DEPT PHARMACOL,LAGOS,NIGERIA
COLL MED LAGOS,DEPT PHARMACOL,LAGOS,NIGERIA
MABADEJE, AFB
[
1
]
机构
:
[1]
COLL MED LAGOS,DEPT PHARMACOL,LAGOS,NIGERIA
来源
:
BIOPHARMACEUTICS & DRUG DISPOSITION
|
1990年
/ 11卷
/ 02期
关键词
:
Antipyrine;
Diltiazem;
Hepatic cytochrome P‐450;
Nifedipine;
Theophylline;
Verapamil;
D O I
:
10.1002/bdd.2510110208
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
On the basis of reports that some calcium channel blockers impair the elimination of some drugs, the effect of nifedipine on the disposition of antipyrine and theophylline was assessed in healthy volunteers. Antipyrine half‐life of 10·04 ± 1·43 h (mean ± SD) after a week intake of nifedipine (20 mg twice daily) was not significantly different from the control value of 10·64 ± 2·15 h; nor was that of 10·02 ± 1·49 h after 2 weeks pretreatment with the calcium channel blocker in eight healthy volunteers. Control antipyrine clearance (ml min−1) of 44·40 ± 10·58 was not significantly different from that of 45·66 ± 9·34 and 46·87 ± 9·63 after nifedipine pretreatment of 1 and 2 weeks, respectively. Similarly volume of distribution was unaltered: 0·601 ± 0·074. 0·591 ± 0·078 and 0·602 ± 0·051 1 kg−1, respectively. A week pretreatment with nifedipine did not significantly alter either of theophylline half‐life (7·32 ± 0·81 h (control) to 7·50 ± 0·80 h) or clearance (42·10 ± 5·84 ml min−1 (control) to 43·77 ± 4·00 ml min−1) in six volunteers. However the change in volume of distribution: 0·451 ± 0·053 1kg−1 (control) to 0·483 ± 0·0621 kg−1 was significant (p < 0·025). Generally, theophylline plasma levels were lower after nifedipine pretreatment and the difference was significant at 2 and 4 h post‐dosing (p < 0·05). It is suggested that nifedipine, unlike diltiazem and verapamil, is unlikely to interfere with the functional integrity of the hepatic mixed‐function oxygenase enzymes, but might displace theophylline from plasma protein. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 27 条
[1]
CAFFEINE DISPOSITION IN OBESITY
ABERNETHY, DR
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
ABERNETHY, DR
TODD, EL
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
TODD, EL
SCHWARTZ, JB
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
SCHWARTZ, JB
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
1985,
20
(01)
: 61
-
66
[2]
CIMETIDINE INHIBITION OF THEOPHYLLINE ELIMINATION - THE INFLUENCE OF ADULT AGE AND THE TIME COURSE
ADEBAYO, GI
论文数:
0
引用数:
0
h-index:
0
机构:
SCH PHARM,DEPT PHARMACEUT CHEM,LAGOS,NIGERIA
SCH PHARM,DEPT PHARMACEUT CHEM,LAGOS,NIGERIA
ADEBAYO, GI
COKER, HAB
论文数:
0
引用数:
0
h-index:
0
机构:
SCH PHARM,DEPT PHARMACEUT CHEM,LAGOS,NIGERIA
SCH PHARM,DEPT PHARMACEUT CHEM,LAGOS,NIGERIA
COKER, HAB
[J].
BIOPHARMACEUTICS & DRUG DISPOSITION,
1987,
8
(02)
: 149
-
158
[3]
THE EFFECT OF VERAPAMIL ON ANTIPYRINE PHARMACOKINETICS AND METABOLISM IN MAN
BACH, D
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
BACH, D
BLEVINS, R
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
BLEVINS, R
KERNER, N
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
KERNER, N
RUBENFIRE, M
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
RUBENFIRE, M
EDWARDS, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
EDWARDS, DJ
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
1986,
21
(06)
: 655
-
659
[4]
BELZ GG, 1981, LANCET, V1, P844
[5]
BENET LZ, 1984, PHARMACOKINETIC BASI, P7
[6]
THE SELECTIVE ACTIVATION OF CYTOCHROME-P-450 DEPENDENT MICROSOMAL HYDROXYLASES IN HUMAN AND RAT-LIVER MICROSOMES
BENFORD, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
BENFORD, DJ
BRIDGES, JW
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
BRIDGES, JW
BOOBIS, AR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
BOOBIS, AR
KAHN, GC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
KAHN, GC
BRODIE, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
BRODIE, MJ
DAVIES, DS
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
DAVIES, DS
[J].
BIOCHEMICAL PHARMACOLOGY,
1981,
30
(12)
: 1702
-
1703
[7]
BRODIE BB, 1949, J BIOL CHEM, V179, P25
[8]
DILTIAZEM TREATMENT IMPAIRS HEPATIC DRUG OXIDATION - STUDIES OF ANTIPYRINE
CARRUM, G
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
CARRUM, G
EGAN, JM
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
EGAN, JM
ABERNETHY, DR
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
ABERNETHY, DR
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1986,
40
(02)
: 140
-
143
[9]
DOW RJ, 1984, BRIT J CLIN PHARMACO, V18, pP296
[10]
DSSING M, 1983, BR J CLIN PHARM, V15, P231
←
1
2
3
→
共 27 条
[1]
CAFFEINE DISPOSITION IN OBESITY
ABERNETHY, DR
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
ABERNETHY, DR
TODD, EL
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
TODD, EL
SCHWARTZ, JB
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
BAYLOR COLL MED,INST LIPID RES,HOUSTON,TX 77030
SCHWARTZ, JB
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
1985,
20
(01)
: 61
-
66
[2]
CIMETIDINE INHIBITION OF THEOPHYLLINE ELIMINATION - THE INFLUENCE OF ADULT AGE AND THE TIME COURSE
ADEBAYO, GI
论文数:
0
引用数:
0
h-index:
0
机构:
SCH PHARM,DEPT PHARMACEUT CHEM,LAGOS,NIGERIA
SCH PHARM,DEPT PHARMACEUT CHEM,LAGOS,NIGERIA
ADEBAYO, GI
COKER, HAB
论文数:
0
引用数:
0
h-index:
0
机构:
SCH PHARM,DEPT PHARMACEUT CHEM,LAGOS,NIGERIA
SCH PHARM,DEPT PHARMACEUT CHEM,LAGOS,NIGERIA
COKER, HAB
[J].
BIOPHARMACEUTICS & DRUG DISPOSITION,
1987,
8
(02)
: 149
-
158
[3]
THE EFFECT OF VERAPAMIL ON ANTIPYRINE PHARMACOKINETICS AND METABOLISM IN MAN
BACH, D
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
BACH, D
BLEVINS, R
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
BLEVINS, R
KERNER, N
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
KERNER, N
RUBENFIRE, M
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
RUBENFIRE, M
EDWARDS, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
EDWARDS, DJ
[J].
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
1986,
21
(06)
: 655
-
659
[4]
BELZ GG, 1981, LANCET, V1, P844
[5]
BENET LZ, 1984, PHARMACOKINETIC BASI, P7
[6]
THE SELECTIVE ACTIVATION OF CYTOCHROME-P-450 DEPENDENT MICROSOMAL HYDROXYLASES IN HUMAN AND RAT-LIVER MICROSOMES
BENFORD, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
BENFORD, DJ
BRIDGES, JW
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
BRIDGES, JW
BOOBIS, AR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
BOOBIS, AR
KAHN, GC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
KAHN, GC
BRODIE, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
BRODIE, MJ
DAVIES, DS
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND
DAVIES, DS
[J].
BIOCHEMICAL PHARMACOLOGY,
1981,
30
(12)
: 1702
-
1703
[7]
BRODIE BB, 1949, J BIOL CHEM, V179, P25
[8]
DILTIAZEM TREATMENT IMPAIRS HEPATIC DRUG OXIDATION - STUDIES OF ANTIPYRINE
CARRUM, G
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
CARRUM, G
EGAN, JM
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
EGAN, JM
ABERNETHY, DR
论文数:
0
引用数:
0
h-index:
0
机构:
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
BAYLOR COLL MED,DEPT MED,HYPERTENS & CLIN PHARMACOL SECT,1 BAYLOR PLAZA,SUITE 826E,HOUSTON,TX 77030
ABERNETHY, DR
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1986,
40
(02)
: 140
-
143
[9]
DOW RJ, 1984, BRIT J CLIN PHARMACO, V18, pP296
[10]
DSSING M, 1983, BR J CLIN PHARM, V15, P231
←
1
2
3
→